APA (7th ed.) Citation

DA, E., WS, S., MM, M., AE, M., GT, E., SM, M., . . . ES, T. (2026). Sustainable One-Pot Synthesis of Novel Triazolopyrimidine Derivatives as Selective CDK4 Inhibitors for Breast Cancer Therapy. Drug development research, 87(4), e70322. https://doi.org/10.1002/ddr.70322

Chicago Style (17th ed.) Citation

DA, Elsayed, Shehab WS, Mohamed MM, Mesbah AE, El-Bassyouni GT, Mousa SM, Abo Elenin OM, Assy MG, and Tantawy ES. "Sustainable One-Pot Synthesis of Novel Triazolopyrimidine Derivatives as Selective CDK4 Inhibitors for Breast Cancer Therapy." Drug Development Research 87, no. 4 (2026): e70322. https://doi.org/10.1002/ddr.70322.

MLA (9th ed.) Citation

DA, Elsayed, et al. "Sustainable One-Pot Synthesis of Novel Triazolopyrimidine Derivatives as Selective CDK4 Inhibitors for Breast Cancer Therapy." Drug Development Research, vol. 87, no. 4, 2026, p. e70322, https://doi.org/10.1002/ddr.70322.